These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30996158)

  • 1. Long-term Effects of Androgen Deprivation in a Patient with Spinal and Bulbar Muscular Atrophy - A Case Report with 14 Years of Follow-up.
    Hijikata Y; Hashizume A; Yamada S; Ito D; Banno H; Suzuki K; Sobue G; Katsuno M
    Intern Med; 2019 Aug; 58(15):2231-2234. PubMed ID: 30996158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
    Banno H; Katsuno M; Suzuki K; Takeuchi Y; Kawashima M; Suga N; Takamori M; Ito M; Nakamura T; Matsuo K; Yamada S; Oki Y; Adachi H; Minamiyama M; Waza M; Atsuta N; Watanabe H; Fujimoto Y; Nakashima T; Tanaka F; Doyu M; Sobue G
    Ann Neurol; 2009 Feb; 65(2):140-50. PubMed ID: 19259967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of leuprorelin acetate for subjects with spinal and bulbar muscular atrophy: pooled analyses of two randomized-controlled trials.
    Hashizume A; Katsuno M; Suzuki K; Banno H; Takeuchi Y; Kawashima M; Suga N; Mano T; Araki A; Hijikata Y; Hirakawa A; Sobue G;
    J Neurol; 2019 May; 266(5):1211-1221. PubMed ID: 30847645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disease-modifying therapy for spinal and bulbar muscular atrophy (SBMA)].
    Suzuki K; Banno H; Katsuno M; Adachi H; Tanaka F; Sobue G
    Brain Nerve; 2012 Mar; 64(3):237-44. PubMed ID: 22402717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy (SBMA).
    Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
    Cell Tissue Res; 2012 Jul; 349(1):313-20. PubMed ID: 22476656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of leuprorelin in spinal and bulbar muscular atrophy: a 3-year observational study.
    Kang MG; Kang M; Cho HJ; Min YS; Park JS
    Neurol Sci; 2024 Aug; 45(8):3853-3859. PubMed ID: 38400888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of spinal and bulbar muscular atrophy with high-stage and high-Gleason Score prostate cancer responded to maximal androgen blockade therapy.
    Kosaka T; Miyajima A; Kikuchi E; Takahashi S; Suzuki N; Oya M
    J Androl; 2012; 33(4):563-5. PubMed ID: 21940987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open trial of long-term testosterone suppression in spinal and bulbar muscular atrophy.
    Yamamoto T; Yokota K; Amao R; Maeno T; Haga N; Taguri M; Ohtsu H; Ichikawa Y; Goto J; Tsuji S
    Muscle Nerve; 2013 Jun; 47(6):816-22. PubMed ID: 23512333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy.
    Banno H; Katsuno M; Suzuki K; Tanaka F; Sobue G
    Int J Mol Sci; 2009 Mar; 10(3):1000-12. PubMed ID: 19399234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.
    Renier KJ; Troxell-Smith SM; Johansen JA; Katsuno M; Adachi H; Sobue G; Chua JP; Sun Kim H; Lieberman AP; Breedlove SM; Jordan CL
    Endocrinology; 2014 Jul; 155(7):2624-34. PubMed ID: 24742193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of leuprorelin in bulbar function of spinal and bulbar muscular atrophy patients: observational study for 1 year.
    Kang MG; Gwak DW; Cho HJ; Min YS; Park JS
    J Neurol; 2021 Sep; 268(9):3344-3351. PubMed ID: 33675422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.
    Katsuno M; Adachi H; Doyu M; Minamiyama M; Sang C; Kobayashi Y; Inukai A; Sobue G
    Nat Med; 2003 Jun; 9(6):768-73. PubMed ID: 12754502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study.
    Hashizume A; Katsuno M; Suzuki K; Hirakawa A; Hijikata Y; Yamada S; Inagaki T; Banno H; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1026-1032. PubMed ID: 28780536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial.
    Katsuno M; Banno H; Suzuki K; Takeuchi Y; Kawashima M; Yabe I; Sasaki H; Aoki M; Morita M; Nakano I; Kanai K; Ito S; Ishikawa K; Mizusawa H; Yamamoto T; Tsuji S; Hasegawa K; Shimohata T; Nishizawa M; Miyajima H; Kanda F; Watanabe Y; Nakashima K; Tsujino A; Yamashita T; Uchino M; Fujimoto Y; Tanaka F; Sobue G;
    Lancet Neurol; 2010 Sep; 9(9):875-84. PubMed ID: 20691641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular-targeted therapies for spinal and bulbar muscular atrophy].
    Katsuno M; Banno H; Suzuki K; Adachi H; Tanaka F; Sobue G
    Rinsho Shinkeigaku; 2009 Nov; 49(11):917-20. PubMed ID: 20030248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Combined Efficacy of a Two-Year Period of Cybernic Treatment With a Wearable Cyborg Hybrid-Assistive Limb and Leuprorelin Therapy in a Patient With Spinal and Bulbar Muscular Atrophy: A Case Report.
    Nakatsuji H; Ikeda T; Hashizume A; Katsuno M; Sobue G; Nakajima T
    Front Neurol; 2022; 13():905613. PubMed ID: 35812096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular-targeted therapy for spinal and bulbar muscular atrophy (SBMA)].
    Sobue G
    Rinsho Shinkeigaku; 2010 Nov; 50(11):839-41. PubMed ID: 21921465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular-targeted therapy for neurodegenerative diseases].
    Sobue G
    Rinsho Shinkeigaku; 2009 Nov; 49(11):747-9. PubMed ID: 20030200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-androgen therapy for spinal and bulbar muscular atrophy (SBMA)].
    Katsuno M; Banno H; Suzuki K; Hashizume A; Adachi H; Tanaka F; Sobue G
    Rinsho Shinkeigaku; 2012; 52(11):1207-9. PubMed ID: 23196565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of treatment of spinal and bulbar muscular atrophy.
    Tanaka F; Katsuno M; Banno H; Suzuki K; Adachi H; Sobue G
    Neural Plast; 2012; 2012():369284. PubMed ID: 22720173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.